Follistatin Like Protein 1 (FSTL1) Antibody (FITC)

Este producto es parte de FSTL - Follistatin-like protein
Product Graph
169€ (20 µg)

Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.

935106861
info@markelab.com
name
Follistatin Like Protein 1 (FSTL1) Antibody (FITC)
category
Primary Antibodies
provider
Abbexa
reference
abx313312

Description

FSTL1 Antibody (FITC) is a Rabbit Polyclonal against FSTL1 conjugated to FITC.

Documents del producto

Instrucciones
Data sheet
Descargar

Product specifications

CategoryPrimary Antibodies
Immunogen TargetFollistatin Like Protein 1 (FSTL1)
HostRabbit
ReactivityHuman
Recommended DilutionOptimal dilutions/concentrations should be determined by the end user.
ClonalityPolyclonal
ConjugationFITC
IsotypeIgG
Purity> 95%
PurificationPurified by Protein G.
Size 120 µg
Size 250 µg
Size 3100 µg
Size 4200 µg
Size 51 mg
FormLiquid
Buffer0.01 M PBS, pH 7.4, 0.03% Proclin-300 and 50% Glycerol.
AvailabilityShipped within 5-10 working days.
StorageAliquot and store at -20°C. Avoid exposure to light. Avoid repeated freeze/thaw cycles.
Dry IceNo
UniProt IDQ12841
Gene ID11167
NCBI AccessionNP_009016.1, NM_007085.4
OMIM605547
AliasFRP,FSL1,OCC1,OCC-1,TSC36,MIR198,Follistatin-related protein 1
BackgroundAntibody anti-FSTL1
StatusRUO

Descripción

Follistatin like 1 (FSTL1) FSTL1 is a secreted glycoprotein that belongs to the SPARC (Secreted Protein Acidic and Rich in Cysteine)-related family and plays diverse roles in development, inflammation, and tissue repair. FSTL1 contains a follistatin-like domain that enables it to interact with various signaling molecules, including members of the TGF-β superfamily. FSTL1 modulates signaling pathways such as BMP (bone morphogenetic protein) signaling, influencing cell differentiation, growth, and immune responses. It is highly expressed in tissues undergoing development or repair, such as the heart, lungs, and skeletal muscles. FSTL1 also exhibits immunomodulatory properties, acting as a pro-inflammatory or anti-inflammatory mediator depending on the context. Dysregulation of FSTL1 has been implicated in inflammatory diseases, cardiovascular conditions, and fibrosis, where it contributes to tissue remodeling and immune dysregulation. In cancer, altered FSTL1 expression can influence tumor progression and metastasis by modulating the tumor microenvironment. Its multifunctional roles in signaling, tissue repair, and immune regulation highlight its potential as a therapeutic target.

Related Products

EH0142

Human FSTL1(Follistatin-related protein 1) ELISA Kit

Ver Producto
EM0595

Mouse Fstl1(Follistatin-related protein 1) ELISA Kit

Ver Producto
ER0961

Rat FSTL1(Follistatin Like Protein 1) ELISA Kit

Ver Producto